Stocks

Investors with an interest in Medical - Biomedical and Genetics stocks have likely encountered both CSL Limited Sponsored ADR (CSLLY) and Acadia Pharmaceuticals (ACAD). But which of these two stocks is more attractive to value investors? We'll need to take a closer look to …

The Zacks Containers - Paper and Packaging industry has been facing weak demand due to lower consumer spending amid an inflationary backdrop. Pricing actions implemented by the industry players will help offset the impacts of supply-chain disruptions and elevated costs and tariffs. The industry …

Yancoal Australia has signed an agreement with EMR Capital Advisors, Kestrel Coal, Adaro Capital and EMR Capital Management to acquire an 80% interest in the Kestrel Coal Mine, with the transaction valued at up to $2.4bn (A$3.36bn). Kestrel is a major underground metallurgical coal …

New ERP enhancements connect FoodReady directly to QuickBooks, Shopify, Xero, and NetSuite, eliminating fragmented data across food manufacturing operations. CHICAGO, April 14, 2026--(BUSINESS WIRE)--FoodReady expanded its food manufacturing ERP capabilities with new modules built for food manufacturers, processors, co-packers, and distributors. The update strengthens …

Lumos secures US$5m FebriDx milestone payment as US rollout gains traction Proactive uses images sourced from Shutterstock Lumos Diagnostics Holdings Ltd (ASX:LDX,OTC:LDXHF) has received a US$5 million milestone pre-payment from its US distribution partner Phase Scientific, with its FebriDx® point-of-care test now moving into …

Highlights: Compelling offer: Pacific Booker shareholders will receive 1.41 American Eagle common shares for each Pacific Booker share held. Lake Babine Nation support: American Eagle has the support of Lake Babine Nation to pursue the acquisition and reset engagement on the Morrison Project. District-scale …

Make better investment decisions with Simply Wall St's easy, visual tools that give you a competitive edge. Worley’s latest analyst updates show a steady modelled fair value at A$14.52 alongside some lower price targets at A$13 and A$12.37. Those cuts are closely tied to …